Role of HDAC inhibitors in diabetes mellitus - 19/04/20
pages | 6 |
Iconographies | 3 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Objective |
The role of histone deacetylases has come out as an emerging remedy in control and treatment of various metabolic disorders and cancers. This review highlights their intricate role in diabetes mellitus as well as its associated complications.
Key findings |
Through recent studies and reports the role of various epigenetic markers in treatment of diabetes mellitus has been revealed. HDAC enzyme regulates the structure of chromatin and transcripts genes in the nucleus synthesizing various proteins that control metabolic activities in the body. It mainly acts by removing an acetyl group from its precursor protein thereby modulating gene expression and regulates the metabolic enzyme acetylation in mitochondria and cytosol.
Summary |
The present review focus on the intrinsic role of HDAC inhibitors as an emerging remedy for diabetes and its complications demonstrating their use in preventing resistance of β-cells towards insulin, destruction of β-cells and provide protection against cytokine mediated attack on pancreatic cells.
Le texte complet de cet article est disponible en PDF.Keywords : Histone deacetylases, Insulin resistance, Acetylation, Transcription, β-cell destruction, Gene expression
Plan
Vol 68 - N° 2
P. 45-50 - avril 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?